(KALU) Kaiser Aluminum - Overview
Stock: Aluminum Plate, Aluminum Tube, Aluminum Rod, Aluminum Sheet, Aluminum Coil
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.66% |
| Yield on Cost 5y | 4.16% |
| Yield CAGR 5y | 1.69% |
| Payout Consistency | 98.2% |
| Payout Ratio | 63.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.3% |
| Relative Tail Risk | -5.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.47 |
| Alpha | 59.83 |
| Character TTM | |
|---|---|
| Beta | 1.194 |
| Beta Downside | 1.110 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.85% |
| CAGR/Max DD | 0.28 |
Description: KALU Kaiser Aluminum January 19, 2026
Kaiser Aluminum Corp. (KALU) manufactures semi-fabricated specialty aluminum mill products, supplying rolled, extruded and drawn alloys to aerospace & defense, packaging, automotive and general engineering markets. Its product mix includes heat-treated aerospace plates, 3000/5000-series coated coils for beverage cans, and 6000-series extrusions for vehicle structures and crash-management systems.
Key operational metrics (FY 2024): revenue $1.55 bn, adjusted EBITDA margin ~13%, and a diversified customer base with ~55 % of sales in the United States and the remainder split among Canada, Western Europe and Asia-Pacific. The company’s exposure to aluminum spot prices is partially hedged, but a 10 % rise in the LME aluminum price historically lifts gross profit by roughly 3 %.
Sector drivers that materially affect KALU are (1) global aerospace and defense spending, which has been rising ~4 % YoY driven by higher demand for commercial jets and military modernization; (2) the rebound in beverage-can demand as emerging-market consumer incomes grow, supporting the 3000/5000-series coil business; and (3) broader macro-economic trends in aluminum supply, where tightening primary-metal capacity and higher scrap-recycling rates can compress margins for secondary-metal producers.
For a deeper quantitative view, you may find ValueRay’s analyst dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 91.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.66 > 1.0 |
| NWC/Revenue: 23.17% < 20% (prev 20.56%; Δ 2.61% < -1%) |
| CFO/TA 0.07 > 3% & CFO 175.4m > Net Income 91.4m |
| Net Debt (1.06b) to EBITDA (286.3m): 3.69 < 3 |
| Current Ratio: 2.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.6m) vs 12m ago 1.70% < -2% |
| Gross Margin: 10.50% > 18% (prev 0.12%; Δ 1038 % > 0.5%) |
| Asset Turnover: 130.9% > 50% (prev 128.9%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: 3.55 > 6 (EBITDA TTM 286.3m / Interest Expense TTM 46.5m) |
Altman Z'' 2.58
| A: 0.29 (Total Current Assets 1.24b - Total Current Liabilities 500.7m) / Total Assets 2.59b |
| B: 0.05 (Retained Earnings 127.1m / Total Assets 2.59b) |
| C: 0.07 (EBIT TTM 165.1m / Avg Total Assets 2.45b) |
| D: 0.09 (Book Value of Equity 154.0m / Total Liabilities 1.79b) |
| Altman-Z'' Score: 2.58 = A |
Beneish M -3.13
| DSRI: 1.02 (Receivables 475.2m/433.1m, Revenue 3.21b/2.98b) |
| GMI: 1.11 (GM 10.50% / 11.65%) |
| AQI: 0.59 (AQ_t 0.05 / AQ_t-1 0.08) |
| SGI: 1.08 (Revenue 3.21b / 2.98b) |
| TATA: -0.03 (NI 91.4m - CFO 175.4m) / TA 2.59b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of KALU shares?
Over the past week, the price has changed by -3.76%, over one month by +4.43%, over three months by +39.17% and over the past year by +79.61%.
Is KALU a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KALU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112.5 | -8.3% |
| Analysts Target Price | 112.5 | -8.3% |
| ValueRay Target Price | 152.7 | 24.5% |
KALU Fundamental Data Overview January 31, 2026
P/E Forward = 27.7008
P/S = 0.6279
P/B = 2.5517
P/EG = 2.24
Revenue TTM = 3.21b USD
EBIT TTM = 165.1m USD
EBITDA TTM = 286.3m USD
Long Term Debt = 1.04b USD (from longTermDebt, last quarter)
Short Term Debt = 7.70m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.06b USD (from netDebt column, last quarter)
Enterprise Value = 3.07b USD (2.02b + Debt 1.07b - CCE 17.2m)
Interest Coverage Ratio = 3.55 (Ebit TTM 165.1m / Interest Expense TTM 46.5m)
EV/FCF = 236.3x (Enterprise Value 3.07b / FCF TTM 13.0m)
FCF Yield = 0.42% (FCF TTM 13.0m / Enterprise Value 3.07b)
FCF Margin = 0.41% (FCF TTM 13.0m / Revenue TTM 3.21b)
Net Margin = 2.85% (Net Income TTM 91.4m / Revenue TTM 3.21b)
Gross Margin = 10.50% ((Revenue TTM 3.21b - Cost of Revenue TTM 2.87b) / Revenue TTM)
Gross Margin QoQ = 9.80% (prev 8.59%)
Tobins Q-Ratio = 1.18 (Enterprise Value 3.07b / Total Assets 2.59b)
Interest Expense / Debt = 1.16% (Interest Expense 12.4m / Debt 1.07b)
Taxrate = 17.36% (8.30m / 47.8m)
NOPAT = 136.4m (EBIT 165.1m * (1 - 17.36%))
Current Ratio = 2.48 (Total Current Assets 1.24b / Total Current Liabilities 500.7m)
Debt / Equity = 1.33 (Debt 1.07b / totalStockholderEquity, last quarter 806.1m)
Debt / EBITDA = 3.69 (Net Debt 1.06b / EBITDA 286.3m)
Debt / FCF = 81.25 (Net Debt 1.06b / FCF TTM 13.0m)
Total Stockholder Equity = 751.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.73% (Net Income 91.4m / Total Assets 2.59b)
RoE = 12.16% (Net Income TTM 91.4m / Total Stockholder Equity 751.7m)
RoCE = 9.20% (EBIT 165.1m / Capital Employed (Equity 751.7m + L.T.Debt 1.04b))
RoIC = 7.57% (NOPAT 136.4m / Invested Capital 1.80b)
WACC = 7.07% (E(2.02b)/V(3.09b) * Re(10.32%) + D(1.07b)/V(3.09b) * Rd(1.16%) * (1-Tc(0.17)))
Discount Rate = 10.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.84%
[DCF Debug] Terminal Value 74.70% ; FCFF base≈27.8m ; Y1≈18.2m ; Y5≈8.33m
Fair Price DCF = N/A (negative equity: EV 195.7m - Net Debt 1.06b = -860.5m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 38.18 | EPS CAGR: -19.86% | SUE: -2.46 | # QB: 0
Revenue Correlation: -34.34 | Revenue CAGR: 1.21% | SUE: -0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.77 | Chg30d=+0.150 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=7.67 | Chg30d=+0.375 | Revisions Net=+1 | Growth EPS=+27.1% | Growth Revenue=+13.0%